drugset / Trial / NCT03312777

Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers

NCT03312777

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study evaluates the analgesic effect of Omnitram and tramadol during concurrent administration of paroxetine. Paroxetine administration is expected to diminish the analgesic effect of tramadol, but not Omnitram. Each participant will receive paroxetine before and during treatment with Omnitram, tramadol, and placebo.

Timeline

Start
2017-10-31
Primary completion
2017-12-15
Completion
2017-12-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmetramadol Small molecule 20 mg Oral
Comparator Tramadol Other / unclassified 50 mg Oral

Indications

No indication recorded.